VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 76 filers reported holding VAXCYTE INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,395,088 | -6.0% | 86,212 | -7.9% | 0.00% | -20.0% |
| Q2 2023 | $4,677,131 | +156.4% | 93,655 | +92.4% | 0.01% | +150.0% |
| Q1 2023 | $1,824,189 | -11.5% | 48,671 | +13.2% | 0.00% | 0.0% |
| Q4 2022 | $2,062,090 | +192.1% | 43,005 | +46.1% | 0.00% | +100.0% |
| Q3 2022 | $706,000 | +35.8% | 29,440 | +23.2% | 0.00% | 0.0% |
| Q2 2022 | $520,000 | +28.4% | 23,897 | +42.8% | 0.00% | – |
| Q1 2022 | $405,000 | -0.2% | 16,731 | -2.1% | 0.00% | – |
| Q4 2021 | $406,000 | +20.5% | 17,090 | +29.2% | 0.00% | – |
| Q3 2021 | $337,000 | +32.7% | 13,226 | +16.9% | 0.00% | – |
| Q2 2021 | $254,000 | -1.2% | 11,310 | -13.3% | 0.00% | – |
| Q1 2021 | $257,000 | -71.3% | 13,042 | -61.3% | 0.00% | – |
| Q4 2020 | $895,000 | – | 33,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $100,049,000 | 34.21% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $45,299,000 | 18.86% |
| Pivotal bioVenture Partners Investment Advisor LLC | 776,039 | $18,625,000 | 6.81% |
| Kynam Capital Management, LP | 698,638 | $16,767,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 600,000 | $14,400,000 | 3.47% |
| Frazier Life Sciences Management, L.P. | 1,547,405 | $37,138,000 | 2.86% |
| Ghost Tree Capital, LLC | 360,000 | $8,640,000 | 2.42% |
| RA Capital Management | 4,581,203 | $109,949,000 | 2.35% |
| Opaleye Management Inc. | 190,000 | $4,560,000 | 1.88% |
| TPG GP A, LLC | 3,285,504 | $78,852,000 | 1.29% |